GLP-1 TV · 22 videos · newest first
Retatrutide explained videos
Retatrutide is not FDA-approved, so these are trial readouts and explainers only, never personal-use videos. How it works and what the trials found. 22 videos, all playable here. For the label facts in writing, read our our guide.
30:34Triple agonist Retatrutide: Wild New DataPat Taylor, MDDetails
A video (MD) explains how retatrutide works and what the evidence says.
Everything about this video
14:00What Is Retatrutide? A Doctor Breaks Down the New Weight Loss Drug.Dr. Joanette MDDetails
A video (MD) explains how retatrutide works and what the evidence says.
Everything about this video
7:25Retatrutide Explained: What Filipinos Need to Know About the Next Weight Loss Drugpinoy endocrinologist (doc ivan cudal)Details
A video explains how retatrutide works and what the evidence says.
Everything about this video
1:24:16Retatrutide Explained: What the New Data Really Show | Dr. Ania Jastreboff & Ted KyleOn The Pen™ GLP-1 NewsDetails
A news or media piece explains how retatrutide works and what the evidence says.
Everything about this video
3:16Eli Lilly Will File For Retatrutide Approval—As Study Shows Average Weight Loss Of 56 PoundsForbes Breaking NewsDetails
A news or media piece explains how retatrutide works and what the evidence says. Also covers the trials.
Everything about this video
15:30What Is Retatrutide? The Triple-Hormone Drug Beating OzempicMike RashidDetails7 key moments
In this video, the channel explains what retatrutide is and what he says the evidence shows. He describes it as an investigational peptide drug candidate designed to act on three receptor pathways: GLP-1, GIP and glucagon.
- 0:00 Intro , why retatrutide is making headlines
- 0:45 What is retatrutide? (the basics)
- 2:30 How a triple-hormone receptor agonist works
- 5:00 Retatrutide vs Ozempic vs Mounjaro
- 8:00 What the Phase 3 trial data actually shows
- 11:00 FDA approval status & realistic timeline
- 13:30 Fact vs. hype , the honest takeaway
- Side effects mentioned: nausea, constipation, diarrhea and muscle loss
2:27Patients in liver failure after using knock-off weight loss drug | ABC NEWSABC News (Australia)Details
This ABC News Australia report follows Megan another speaker, a 32-year-old who became seriously ill after injecting a peptide she bought from a beautician to lose a few kilos.
Everything about this video
4:25Do you refrigerate retatrutide? Storage guidance explainedBolt Pharmacy UKDetails
According to the video, retatrutide is an investigational injectable that targets three receptors (GLP-1, GIP and glucagon) and is available only through regulated clinical trials.
Everything about this video
14:52Retatrutide Isn't a Weight Loss Drug — Here's What It Really Does (Weightloss Dr. Explains)Dr. Kevin Joseph, DODetails8 key moments
The speaker, who says he specializes in obesity medicine and peptide therapy, argues that retatrutide should not be judged only by weight loss. He describes it as a once-weekly injection from Eli Lilly that activates three receptors: GLP-1, GIP and glucagon.
- 0:00 The case for retatrutide
- 1:00 Mechanism of action
- 2:10 How the three switches work
- 4:08 Weight loss clinical results
- 5:14 Impact on liver health
- 8:31 Joint health and mobility
- 10:11 Cardiovascular and lipid data
- 11:12 Kidney and respiratory health
9:28Orforglipron Vs Retatrutide?Regan ArchibaldDetails6 key moments
In this video, the channel, who introduces himself as founder of Ageless Future, compares orforglipron, an oral once-daily GLP-1 medication, with retatrutide, an investigational weekly injection.
- 0:00 Intro & Summary
- 1:37 What Is Orforglipron?
- 4:32 Potential Side Effects & Considerations
- 5:12 Orforglipron Clinical Results & Head-to-Head Comparison
- 7:13 Retatrutide: Benefits, Research & Weight Loss Data
- 9:07 Work With Us
20:32Retatrutide Before FDA Approval? Lilly Just Changed the ConversationOn The Pen™ GLP-1 NewsDetails4 key moments
In this episode of the Weekly Dose podcast from On The Pen, the speaker reports on a ClinicalTrials.gov listing that he says points to a pre-approval expanded access program for retatrutide from Eli Lilly.
- Side effects mentioned: fatigue
2:11Safety concerns over doctors prescribing experimental weight loss drug not approved by FDACBS Evening NewsDetails
According to this segment, a CBS News investigation found that doctors and other providers are offering an experimental weight loss drug called Retatide online, even though it is still in clinical trials and has not been approved by the FDA.
Everything about this video
3:19Doctors caught promoting unregulated weight-loss drug retatrutide, CBS News findsCBS NewsDetails
According to the video, the channel investigation looked at retatrutide, an injectable drug that is popular online under the nickname "Retatide" and is described as promising to curb hunger, shed fat and retain muscle.
Everything about this video
20:44Dr Explains - 7 Things to Never Mix with RetatrutideDr. Kevin Joseph, DODetails8 key moments
The speaker, an internal medicine physician and medical director, says more of his patients are getting retatrutide through gray market sources, medical spas and compounding pharmacies. He made the video to explain seven things to avoid or watch closely while taking it.
- 0:00 Intro
- 1:25 Corticosteroids
- 7:00 Overactive thyroid/thyroid medications
- 9:38 Insulin secretagogues
- 11:45 Phenteramine
- 14:18 Over the counter stimulants
- 16:20 Alcohol use
- 17:30 Diuretics
- Side effects mentioned: dizziness, dehydration and pancreatitis
2:55New data released on weight loss drug retatrutideGood Morning AmericaDetails3 key moments
This segment features the show's chief medical correspondent, who discusses retatrutide, an experimental weight loss medication still in clinical trials. According to the video, it is a once-a-week injection that targets three hormones: GLP-1, GIP and glucagon.
Everything about this video
17:01Tirzepatide or Retatrutide? Analyzing the Newest Clinical DataOn The Pen™ GLP-1 NewsDetails7 key moments
The host of On The Pen GLP-1 News reacts to Eli Lilly's new phase three top-line data for retatrutide from the Triumph 1 study.
- 0:00 Introduction to study data
- 2:16 Phase 3 clinical trial results
- 3:55 Analyzing real-world efficacy
- 5:42 Tolerability and side effects
- 7:37 Lilly's broad strategy
- 8:45 Legal and regulatory outlook
- 10:53 Market positioning and future
- Side effects mentioned: nausea, vomiting, constipation, diarrhea and bloating
31:10Retatrutide Explained: The Triple-Agonist After Ozempic and MounjaroBioavailableDetails8 key moments
According to the video, retatrutide is an investigational once-weekly injection from Lilly, built as a single molecule that activates the GIP, GLP-1 and glucagon receptors.
- 0:00 Understanding retatrutide
- 3:28 The role of GIP signaling
- 6:12 The glucagon mechanism
- 8:58 Health outcomes and dashboards
- 12:45 Interpreting patient outcomes
- 13:38 Evidence vs. speculation
- 15:54 Phase 2 trial evidence
- 16:22 Dosing and escalation
- Side effects mentioned: nausea, vomiting and diarrhea
9:38Retatrutide, Too Good to Be True? A Dietitian Explains this new GLP-1GLP-1 HubDetails8 key moments
In this video, the speaker, a registered dietitian who says she also uses a GLP-1 medication, discusses retatrutide, an experimental drug from Eli Lilly. She says it is in phase three clinical trials and is not FDA approved.
- 0:00 A New Weight loss drug appears
- 0:45 Meet Retatrutide
- 1:34 How effective is Retatrutide?
- 2:29 What is Retatutide?
- 3:07 What makes Retatrutide so effective?
- 4:00 Eli Lilly's Retatrutide study result
- 5:40 Retatrutide too effective?
- 6:06 The effects of rapid weight loss
- Side effects mentioned: muscle loss
7:38-24% weight loss? Retatrutide vs. #Mounjaro, #ozempic and #Wegovy – the truth🔥 "The Healthy Evolution"Details
A video explains how Ozempic works and what the evidence says.
Everything about this video
11:14Ozempic vs Zepound vs Retatrutide | Which is Best for Weight Loss?Dr. Stirrett Details8 key moments
In this video, the channel compares three GLP-1 options: semaglutide (sold as Ozempic or Wegovy), tirzepatide (Zepbound or Mounjaro, or labeled simply as tirzepatide from a compounding pharmacy), and retatrutide.
- 0:00 Introduction: Should You Switch Your GLP-1?
- 0:25 Overview of GLP-1 Medications
- 0:53 Semaglutide: Benefits and Side Effects
- 1:29 Tirzepatide: A Broader Approach
- 2:07 Retatrutide: The New Hype
- 2:49 Key Considerations for Switching Medications
- 6:27 When to Consider Switching to Tirzepatide
- 8:10 Retatrutide: Is It Worth It?
- Side effects mentioned: nausea and constipation
5:32🚨🚨🚨BREAKING NEWS ON: #Retatrutide from #EliLilly makers of #MounjaroOn The Pen™ GLP-1 NewsDetails4 key moments
In this short video from the On The Pen channel, the host, who gives his name as the speaker, reacts to newly released clinical trial data on retatrutide from Eli Lilly.
Everything about this video
7:07Retatrutide enters phase 3 clinical trials, what does that mean?On The Pen™ GLP-1 NewsDetails
According to the video, the host uses this episode to explain how clinical trial phases work and where Eli Lilly's upcoming weight loss drugs sit within them.
Everything about this videoWatched enough? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.



